CMS revises rates for 2014 following heated protests from Congress, beneficiaries
April brought good news to Medicare Advantage (MA) plans. The Centers for Medicare and Medicaid Services (CMS) pulled back on its earlier proposal to sharply reduce plan payments for 2014, a policy that had set off a ruckus in the industry and on Capitol Hill.
Thousands of the 14 million MA plan members wrote members of Congress protesting potentially higher premiums and loss of MA coverage. That prompted more than160 legislators to press CMS to re-evaluate its rate-setting formula.
Health and Human Services (HHS) secretary Kathleen Sebelius responded, evidently hoping that the move would help win Republican support for confirmation of Marilynn Tavenner as CMS administrator.
MA plans still face rate reductions steeper than cost trends, largely attributed to payment reforms enacted in the Patient Protection and Affordable Care Act (PPACA). A new excise tax will raise costs, and budget cuts will dampen revenues. Final rates, which will vary greatly by county, benefit design and other factors, will be shaped by changes in how CMS sets benchmarks for plan bids, adjusts for coding intensity, awards bonus payments to plans achieving high star quality ratings, and implements other policy revisions. But the final fee will be more attractive than that proposed a few months ago.
The MA rate problem began in mid-February when CMS proposed a 2.2% reduction in cost trends, a number that reflected the actuaries’ usual practice of basing rates on current law. That assumed a 25% reduction in doctors’ fees under the sustainable growth rate (SGR) formula. But HHS agreed with critics that policymakers will prop up Medicare provider fees and that MA plans will end up paying doctors what they do today. So instead of a sharp drop in trend, the April final call letter projected a 3.3% growth rate.
Consequently, MA plan rates are projected to decline 2% to 3% for 2014, as opposed to the 7% to 8% cut previously anticipated.
CMS’s decision to to set MA rates based on current fees to physicians increases pressure on Congress and the White House to tackle the doc fix sooner, rather than later. While another short-term SGR patch is likely, there is greater support for negotiating a more permanent solution for the flawed physician payment formula.
A serious move to revise the SGR could encompass broader changes in the traditional Medicare program, which are surfacing in budget negotiations between the Obama administration and Congress. One proposal is to combine Medicare Part A and Part B coverage to create a single deductible and cap on out-of-pocket costs for both programs. Beneficiary protection from catastrophic costs would reduce the need for Medigap plans with first dollar coverage, making seniors more sensitive to costs and likely to avoid unnecessary care.
Further MA reforms would be part of the package. The Medicare Payment Advisory Commission (MedPAC) acknowledged in its March report to Congress that the gap is closing between MA plan payments and prevailing traditional Medicare, but that there’s still room to revise benchmarks to achieve parity. The Government Accountability Office similarly noted in a March report that MA plans received some $5 billion in overpayments between 2010 and 2012 due to upcoding of risk scores that classify members as sicker than normal.
The promise of the MA program is that health plans will reduce Medicare spending by better coordinating care for elderly patients with multiple chronic conditions and high costs. The challenge is to curb expenditures sufficiently to support reduced plan payments.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More